Meeting to be held in Minneapolis on March 26 and in Milwaukee on March 27 hosted by Stephens.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CSTL:
- Castle Biosciences: Strong Buy Rating Driven by TissueCypher’s Promising Growth and Strategic Market Positioning
- Castle Biosciences’ 2024 Earnings: Growth Amid Challenges
- Castle Biosciences: Strong Growth Potential Despite Challenges, Buy Rating Affirmed
- Castle Biosciences price target raised to $37 from $36 at Baird
- Castle Biosciences: Strong Growth Potential and Robust Performance Justify Buy Rating